Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/14/1998 | WO1998001558A3 Protein and peptide vaccines for inducing mucosal immunity |
05/14/1998 | WO1997048801A3 Polynucleotides encoding secreted proteins |
05/14/1998 | WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor |
05/14/1998 | DE19647697A1 Verfahren zur genetischen Kontrolle der Samenreifung in Pflanzen Methods for the genetic control of seed maturation in plants |
05/14/1998 | DE19640817A1 Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1 A recombinant preparation process for a complete malaria antigen gp190 / MSP 1 |
05/14/1998 | CA2790915A1 Method, tools and kits for the detection of members of the streptococcus genus |
05/14/1998 | CA2789369A1 Method, tools and kits for the detection of members of the staphylococcus genus |
05/14/1998 | CA2275535A1 Secreted proteins and polynucleotides encoding them |
05/14/1998 | CA2273185A1 Compositions and uses for sentrin, a cell-death protecting protein |
05/14/1998 | CA2272991A1 Disruption of the mammalian rad51 protein and disruption of proteins that associate with mammalian rad51 for hindering cell proliferation |
05/14/1998 | CA2271291A1 Protease-activatable pseudomonas exotoxin a-like proproteins |
05/14/1998 | CA2271235A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
05/14/1998 | CA2270909A1 Novel histamine h2 receptor |
05/14/1998 | CA2270905A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
05/14/1998 | CA2270869A1 Constrained helical peptides and methods of making same |
05/14/1998 | CA2270431A1 Method for the detection of compounds that modulate the effects of the obese (ob) protein |
05/14/1998 | CA2270284A1 Contryphan peptides |
05/14/1998 | CA2270282A1 Novel coding sequences from herpes simplex virus type-2 |
05/14/1998 | CA2270173A1 Tumor-associated kazal inhibitor with pec-60 homology |
05/14/1998 | CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
05/14/1998 | CA2270160A1 Endothelium specific expression regulated by epcr control elements |
05/14/1998 | CA2269757A1 Structure of secretory immunoglobulin a |
05/14/1998 | CA2269666A1 Herbicide resistant plants |
05/14/1998 | CA2269665A1 Human regulator of g-protein signaling - (hrgs) |
05/14/1998 | CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof |
05/14/1998 | CA2269641A1 Sprouty protein and coding sequence |
05/14/1998 | CA2268926A1 Process for the extraction of proteins |
05/14/1998 | CA2268354A1 Soluble proteins |
05/14/1998 | CA2264610A1 Branched peptide linkers |
05/14/1998 | CA2263199A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it |
05/14/1998 | CA2241911A1 Secreted proteins |
05/14/1998 | CA2239463A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
05/13/1998 | EP0841400A1 Vector for the bacterial expression of recombinant antibody- and/or cytokine-toxin fusion proteins |
05/13/1998 | EP0841399A2 Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor |
05/13/1998 | EP0841396A1 Human telomerase catalytic subunit |
05/13/1998 | EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses |
05/13/1998 | EP0841393A1 HUMAN GALECTIN-4-LIKE PROTEIN AND cDNA ENCODING THE SAME |
05/13/1998 | EP0841392A2 Attenuated live neospora vaccine |
05/13/1998 | EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
05/13/1998 | EP0840801A2 Methods and compositions for identifying morphogen analogs |
05/13/1998 | EP0840797A1 Methods and means for targeted gene delivery |
05/13/1998 | EP0840795A1 Helper virus-free herpesvirus vector packaging system |
05/13/1998 | EP0840794A1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
05/13/1998 | EP0840793A2 An expression control sequence for general and effective expression of genes in plants |
05/13/1998 | EP0840791A2 Generation of immune responses to prostate-specific antigen (psa) |
05/13/1998 | EP0840788A1 Novel serpin derived from human hypothalamus |
05/13/1998 | EP0840787A2 A human edg-2 receptor homolog |
05/13/1998 | EP0840786A1 Gdu, a novel signalling protein |
05/13/1998 | EP0840785A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor |
05/13/1998 | EP0840784A1 Method of producing and purifying enzymes |
05/13/1998 | EP0840782A1 Pap mutants that exhibit anti-viral and/or anti-fungal activity in plants |
05/13/1998 | EP0840750A1 Ha-2 antigenic peptide |
05/13/1998 | EP0840749A1 The h-y antigen |
05/13/1998 | EP0840748A1 Transforming growth factor beta crystals |
05/13/1998 | EP0840747A1 Papillomavirus polyprotein constructs |
05/13/1998 | EP0840746A2 Method for the purification of proteins |
05/13/1998 | EP0840745A2 Process for protein refolding by means of buffer exchange using a continuous stationary phase capable of separating proteins from salt |
05/13/1998 | EP0840742A1 Systematic evolution of ligands by exponential enrichment: chemi-selex |
05/13/1998 | EP0840741A1 Pna-dna chimeras and pna synthons for their preparation |
05/13/1998 | EP0840736A1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
05/13/1998 | EP0840729A1 Inhibitors of phospholipase a 2? |
05/13/1998 | EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
05/13/1998 | EP0840619A1 Prevention and treatment of sepsis |
05/13/1998 | EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
05/13/1998 | EP0840615A2 Chemokine binding protein and methods of use therefor |
05/13/1998 | EP0782583A4 Method of measuring thymopoietin proteins in plasma and serum |
05/13/1998 | EP0733062B1 Protecting nucleic acids and methods of analysis |
05/13/1998 | EP0696325B1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
05/13/1998 | EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
05/13/1998 | EP0651883B1 Peptides useful as internal standards for microsequencing and methods for their use |
05/13/1998 | EP0651813B1 A brassica regulatory sequence for root-specific or root-abundant gene expression |
05/13/1998 | EP0625162B1 Methods of producing analgesia and enhancing opiate analgesia |
05/13/1998 | EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
05/13/1998 | EP0575522B1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
05/13/1998 | EP0573614B1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
05/13/1998 | EP0406286B1 Dna encoding a ryegrass pollen allergen |
05/13/1998 | EP0375736B1 Nucleic acid fragments encoding mannose binding fragments of human mannose binding protein |
05/13/1998 | CN1181784A Genes encoding lymphocyte interferon regulatory factor (LSIRF) polypeptides |
05/13/1998 | CN1181783A Medical composition |
05/13/1998 | CN1181782A Process for the prepn. of factor IX from biological sources |
05/13/1998 | CN1181761A Antigen compsn. against mycoplasma |
05/13/1998 | CN1181760A Lipophilic peptide hormone derivatives |
05/13/1998 | CN1181759A Process for the purification of glycoproteins like erythropoietin |
05/13/1998 | CN1181704A Use of glial neurotrophic factor (GDND) for treatment of hearing disorders |
05/13/1998 | CN1038304C Method for prepn. of growth inhibiting compsn. |
05/12/1998 | US5750874 Plant cells that disable fungal infections in transgenic plants |
05/12/1998 | US5750873 Nucleic acid molecules that encode tassel seed 2(TS2), a protein involved in the control of flower development in plants |
05/12/1998 | US5750868 Using a dna adenine methylating gene as a dominant negative gene and a promoter to reverse male sterility in maize |
05/12/1998 | US5750865 Process for modifying the production of carotenoids in plants, and DNA, constructs and cells therefor |
05/12/1998 | US5750864 Delaying wound-induced ripening of fruit |
05/12/1998 | US5750862 Control of plant cell proliferation and growth |
05/12/1998 | US5750826 Bradykinin B2 receptor modified transgenic non-human animals |
05/12/1998 | US5750825 Research on heart disease |
05/12/1998 | US5750725 Hemoglobin crosslinkers |
05/12/1998 | US5750697 A glycol adduct of amiloride; blocking by binding to protein; hypotensive agents; urogenital disorders; diuresis; dietetics; glaucoma; diagnosis/medical/ |
05/12/1998 | US5750667 System to detect protein-RNA interactions |
05/12/1998 | US5750659 Mammalian growth factor |
05/12/1998 | US5750658 Fibrinogen processing apparatus, method and container |
05/12/1998 | US5750657 Methods and compositions using fibrin monomer to make a fibrin sealant |
05/12/1998 | US5750654 Leukaemia inhibitory factor |